Biotech · Private company
BHR Pharma, LLC
Track this companyFree. Adds BHR Pharma, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- 4-OH tamoxifenPhase 3 · Mammographic Breast DensityClinicalTrials.gov · fetched Nov 12, 2026
- Lipid emulsion without progesteronePhase 3 · Brain InjuriesClinicalTrials.gov · fetched Nov 12, 2026
- ProgesteronePhase 3 · Brain InjuriesClinicalTrials.gov · fetched Nov 12, 2026
- BHR-200 (0.36% transdermal 17β-estradiol gel)Phase 2 · Cancer of the ProstateClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Trial of 4-Hydroxytamoxifen (4-OHT) Gel in Women Aimed at Reducing Dense Breast TissuePHASE3 · TERMINATED · started Aug 21, 2017ClinicalTrials.gov NCT03199963 · fetched Nov 12, 2026
- Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the BreastPHASE2 · COMPLETED · started May 31, 2017ClinicalTrials.gov NCT02993159 · fetched Nov 12, 2026
- Maintaining Suppression of Testosterone With Transdermal Estradiol GelPHASE2 · TERMINATED · started Jul 1, 2015ClinicalTrials.gov NCT02349386 · fetched Nov 12, 2026
- Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain InjuryPHASE3 · COMPLETED · started Jun 1, 2010ClinicalTrials.gov NCT01143064 · fetched Nov 12, 2026